Who We Are

 

TRPV Pharmaceuticals is a clinical stage specialty pharmaceutical company focused on the development of new drug products based on the calcium permeable transient receptor potential vanilloid channels (TRPV).

The company licenses and develops TRPV channel modulators with specific focus on cardiovascular health.

Our Mission

  • Develop and commercialize life changing cardiovascular drugs based on TRPV channel modulators.

  • Establish our drugs as the new standard of care for cardiovascular disease.

  • Develop additive manufacturing based delivery systems to enable personalized dosing and better clinical outcomes.

  • Focus on affordability for patients and healthcare providers while maximizing shareholder value.